SCHEMBL19765397

SCHEMBL19765397

Cc1cc2c(cc1-c1cccc3c1Oc1ccccc1C3(C)C)-c1ccccc1-c1ccccc1-c1ccccc1-2

nearest known ligand 0.36

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
DRD1 P21728 1/20 0.36
MEN1 O00255 1/20 0.30
NPC1 O15118 1/20 0.30
USP2 O75604 1/20 0.30
POLB P06746 1/20 0.30
MAPT P10636 1/20 0.30
HTT P42858 1/20 0.30
RAB9A P51151 1/20 0.30
KMT2A Q03164 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
AHR P35869 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19765310 0.96 DRD1 (0.39) DRD1POLBMAPTAHR
SCHEMBL25592999 0.83 DRD1 (0.32) DRD1
SCHEMBL19765409 0.82 DRD1 (0.34) DRD1
SCHEMBL19765315 0.81 DRD1 (0.33) DRD1
SCHEMBL19765400 0.81 DRD1 (0.40) DRD1MEN1NPC1USP2POLB
SCHEMBL19765337 0.80 PDK2 (0.33) DRD1MEN1KMT2A
SCHEMBL19765392 0.79 DRD1 (0.35) DRD1
SCHEMBL19765410 0.78 DRD1 (0.34) DRD1
SCHEMBL16773716 0.78 DRD1 (0.44) DRD1AHR
SCHEMBL23697027 0.78 DRD1 (0.39) DRD1MAPTSMN1; SMN2AHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230174502-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2023-06-08 US disclosed
US-20180013075-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2018-01-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180013075-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES ANKK1, EYA2, KCNN2 DRD1 1142/4885MEN1 2807/4885NPC1 4052/4885
US-20230174502-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES PAX2, PAX3, HPRT1 DRD1 1490/4885MEN1 3473/4885NPC1 2576/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.